Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults (Q40114912)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults |
scientific article |
Statements
1 reference
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults (English)
1 reference
1 reference
M Juliana McElrath
1 reference
David C Montefiori
1 reference
Lindsey R Baden
1 reference
Georgia D Tomaras
1 reference
Harriet L Robinson
1 reference
Nicole A Grunenberg
1 reference
Brittany J Sanchez
1 reference
M Anthony Moody
1 reference
Nicole Frahm
1 reference
Christine M Hay
1 reference
Paul A Goepfert
1 reference
Xuesong Yu
1 reference
Peter B Gilbert
1 reference
HIV Vaccine Trials Network (HVTN) 094 Study Group
1 reference
20 July 2017
1 reference
1 reference
12
1 reference
7
1 reference
e0179597
1 reference
20 July 2017
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference